Neobook — clinical reference

Overview

Definition and Pathophysiology

Clinical Presentation

Differential Diagnosis

References and Guidelines

Notes for HCPs

Clinical Highlights

Overview

Condition

Name: Acute Cystitis
ICD-10 Code: N30.0 (Cystitis, unspecified = N30.9; Other chronic cystitis = N30.2)

Epidemiology

Prevalence

Acute cystitis is a common condition, particularly in women
The exact prevalence in South Africa needs to be better documented but is assumed to mirror global rates
It affects approximately 50-60% of women at least once in their lifetime

Sex Differences

Significantly more common in females due to anatomical differences
Female-to-male ratio is approximately 8:1

Age of Onset

Most frequently occurs in sexually active women aged 20-40 years
Incidence increases again in postmenopausal women

Regional and Socioeconomic Variations

Higher prevalence in urban areas compared to rural areas, possibly due to differences in access to healthcare and lifestyle factors
Socioeconomic status impacts prevalence, with higher rates observed in higher-income groups due to lifestyle and healthcare access

Impact on Quality of Life

Acute cystitis can significantly impact daily functioning, leading to increased healthcare utilisation and absenteeism from work or school
Frequent recurrences can cause substantial discomfort and anxiety

Risk Factors

Sexual activity

Increased risk associated with sexual intercourse, particularly with new or multiple partners
Use of spermicides can disrupt the normal vaginal flora, increasing susceptibility

Previous urinary tract infections

History of recurrent UTIs increases the likelihood of developing acute cystitis

Diabetes

Diabetic patients are at higher risk due to possible alterations in immune function and glycosuria

Postmenopausal status

Decreased oestrogen levels can lead to changes in the urinary tract, increasing the risk of infection

Urinary tract abnormalities

Anatomical abnormalities such as vesicoureteral reflux or bladder diverticula can predispose to infections

Catheterisation

Use of urinary catheters is a significant risk factor for developing acute cystitis

Immunosuppression

Conditions that weaken the immune system, such as HIV or immunosuppressive therapies, increase risk

Lifestyle factors

Poor hygiene practices and certain contraceptive methods, like diaphragms, can increase risk
Dehydration and infrequent urination can contribute to the development of cystitis

Definition and Pathophysiology

Definition

Acute cystitis is an infection of the urinary bladder, predominantly caused by bacteria
It is characterised by inflammation of the bladder wall and is typically associated with lower urinary tract symptoms such as dysuria, urgency, and frequency
The condition is diagnosed based on clinical symptoms and confirmed by urinalysis and urine culture
It is more common in women due to anatomical factors but can occur in men, especially those with underlying urological conditions

Pathophysiology

Bacterial ascension

The most common pathogen is Escherichia coli, which ascends from the urethra into the bladder
Other pathogens include Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis

Host defences

The urinary tract has several defence mechanisms, including urine flow, mucosal barriers, and immune responses
Disruption of these defences, such as through catheter use or sexual activity, can predispose to infection

Adhesion factors

Uropathogenic bacteria have adhesion factors (fimbriae) that allow them to attach to the uroepithelium, evading the flushing action of urine

Inflammatory response

Bacterial infection triggers an inflammatory response, leading to the release of cytokines and other inflammatory mediators
This results in the characteristic symptoms of cystitis, such as pain and urgency

Epithelial damage

The bacteria can cause direct damage to the bladder epithelium, exacerbating inflammation and symptoms
Repeated infections can lead to chronic changes in the bladder wall

Immune response

Local immune cells (macrophages, neutrophils) respond to bacterial invasion, further amplifying the inflammatory response
This can sometimes lead to symptoms persisting even after bacterial clearance

Biofilm formation

Some bacteria can form biofilms, which protect them from the host immune system and antibiotics, contributing to recurrent infections

Risk factors impacting pathophysiology

Sexual activity: Can introduce bacteria into the urinary tract
Postmenopausal changes: Reduced oestrogen levels affect the normal flora and mucosal integrity
Diabetes: Hyperglycaemia can impair immune function and promote bacterial growth
Urinary stasis: Conditions causing incomplete bladder emptying (e.g., neurogenic bladder, enlarged prostate) increase infection risk

Clinical Presentation

Symptoms

Dysuria

Painful or burning sensation during urination
Common and often the primary complaint

Urinary frequency

Increased frequency of urination, often with small volumes
Patients may feel the need to urinate more than usual

Urgency

Sudden, strong urge to urinate
Can be difficult to delay urination

Suprapubic pain

Pain or discomfort in the lower abdomen, just above the pubic bone
Typically, a dull, pressure-like pain that may worsen with bladder filling

Haematuria

Presence of blood in the urine
Can be microscopic or visible to the naked eye (gross haematuria)

Nocturia

Waking up at night to urinate
Can disrupt sleep and contribute to fatigue

General Malaise

A feeling of overall discomfort or uneasiness
May include low-grade fever and fatigue

Signs

Suprapubic tenderness

Tenderness upon palpation of the lower abdomen
Typically mild but can be more pronounced in severe cases

Normal physical examination

Physical examination may be unremarkable aside from suprapubic tenderness
No systemic signs of illness such as high fever or chills (distinguishes from pyelonephritis)

Diagnostic Criteria

Clinical Diagnosis

Based primarily on symptoms of dysuria, frequency, urgency, and suprapubic pain
Confirmed by urinalysis showing pyuria (white blood cells in urine) and bacteriuria (bacteria in urine)

Urinalysis

Presence of leukocyte esterase and nitrites
Microscopic examination showing white blood cells and bacteria

Additional Diagnostic Considerations

Recurrent or complicated infections

Consider further evaluation for underlying abnormalities such as urinary tract obstruction or immune deficiencies
Imaging studies (e.g., ultrasound, CT scan) may be warranted

Non-infectious causes of symptoms

Consider interstitial cystitis, urethritis, and other non-infectious causes if typical antibiotic therapy fails
Referral to a specialist may be necessary for atypical presentations

Functional Impact

Quality of life

Acute cystitis can cause significant discomfort and anxiety
Frequent urination and pain can disrupt daily activities, work, and sleep

Patient-Reported Outcomes

Utilisation of symptom diaries to track frequency and severity of symptoms
Assessment of treatment efficacy and impact on daily life

Differential Diagnosis

Conditions to Consider

Pyelonephritis

An upper urinary tract infection involving the kidneys
Symptoms include fever, flank pain, nausea, and vomiting
More severe systemic symptoms compared to acute cystitis

Urethritis

Inflammation of the urethra, often due to sexually transmitted infections (STIs)
Symptoms include dysuria and urethral discharge
Common pathogens include Chlamydia trachomatis and Neisseria gonorrhoeae

Vaginitis

Inflammation of the vagina, often caused by infections such as bacterial vaginosis, candidiasis, or trichomoniasis
Symptoms include vaginal discharge, itching, and irritation
Distinguishable from cystitis by the presence of vaginal symptoms

Interstitial cystitis (bladder pain syndrome - BPS)

A chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain
Symptoms include urgency, frequency, and chronic pelvic pain
No bacterial infection present on urine culture

Prostatitis

Inflammation of the prostate gland, causing urinary symptoms and pelvic pain
Symptoms include dysuria, perineal pain, and sometimes fever and chills
Can be bacterial or non-bacterial

Sexually transmitted infections (STIs)

Conditions such as chlamydia and gonorrhoea can present with urinary symptoms
Additional symptoms include genital discharge and pelvic pain
Requires specific testing and treatment

Nephrolithiasis (kidney stones)

Presence of stones in the urinary tract causing pain and haematuria
Symptoms include severe flank pain radiating to the groin, haematuria, and nausea
Can be confirmed with imaging studies such as a CT scan

Pelvic inflammatory disease (PID)

Infection of the female reproductive organs, often associated with STIs
Symptoms include lower abdominal pain, fever, and abnormal vaginal discharge
Can cause significant complications if untreated

Atrophic vaginitis

Inflammation of the vagina and urethra due to decreased oestrogen levels in postmenopausal women
Symptoms include vaginal dryness, itching, and urinary symptoms similar to cystitis

Key Differentiators

Pyelonephritis

Presence of fever, flank pain, and systemic symptoms
Positive urine culture and often elevated white blood cell count

Urethritis

Urethral discharge and positive test for STIs
Absence of bladder-specific symptoms like suprapubic pain

Vaginitis

Vaginal symptoms and abnormal vaginal discharge
Negative urine culture for typical uropathogens

Interstitial cystitis

Chronic bladder pain and urgency without infection
Diagnosis of exclusion after ruling out infections

Prostatitis

Perineal or pelvic pain and possibly systemic symptoms
Digital rectal exam reveals a tender prostate

STIs

Positive tests for specific pathogens such as Chlamydia or Gonorrhoea
Symptoms of genital infection and possible urethritis

Nephrolithiasis

Severe, colicky flank pain and haematuria
Confirmed by imaging studies showing stones

PID

Lower abdominal pain, fever, and cervical motion tenderness
Positive tests for STIs and elevated inflammatory markers

Atrophic vaginitis

Vaginal atrophy and dryness, often in postmenopausal women
Improvement with topical oestrogen therapy

Diagnostic Tests

Initial Tests

Urine dipstick testing

Quick assessment

Provides immediate results for leukocyte esterase, nitrites, protein, and blood, useful for initial assessment in clinical settings

Urinalysis

Leukocyte esterase and nitrites

Presence indicates bacterial infection

Microscopic examination

Identifies white blood cells (pyuria), red blood cells (haematuria), and bacteria (bacteriuria)

pH level

Alkaline pH may suggest Proteus infection

Urine culture and sensitivity

Bacterial identification

Confirms the presence of uropathogenic bacteria

Colony count

Significant bacteriuria is defined as >100,000 CFU/mL

Antibiotic sensitivity

Guides appropriate antibiotic therapy based on bacterial resistance patterns

Full blood count (FBC)

Leukocytosis

Elevated white blood cell count may indicate a systemic response to infection

Anaemia

Not typical in uncomplicated cystitis but may warrant further investigation if present

C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR)

Inflammatory markers

Elevated levels can indicate systemic inflammation, suggesting a more severe infection or complication like pyelonephritis

Advanced Tests

Urine cytology

Atypical cells

Used if there is suspicion of bladder cancer, especially in cases of persistent haematuria not explained by infection

Cystoscopy

Bladder visualisation

Direct visualisation of the bladder and urethra, indicated in recurrent infections or when malignancy is suspected

Biopsy

Allows for biopsy of suspicious areas if needed

Voiding cystourethrogram (VCUG)

Vesicoureteral reflux

Identifies reflux of urine from the bladder back into the ureters and kidneys, a condition that can predispose to recurrent infections

Imaging Studies

Ultrasound

Kidneys and bladder

Useful for identifying structural abnormalities, stones, or obstruction

Post-void residual

Measures the amount of urine left in the bladder after urination, which can indicate incomplete bladder emptying

CT Scan

Detailed imaging

Useful in complex cases to identify stones, abscesses, or anatomical abnormalities

Urography

Provides detailed images of the urinary tract, helpful in diagnosing recurrent or complicated infections

Additional Diagnostic Considerations

Screening for diabetes

Blood glucose levels

Hyperglycaemia can predispose to urinary tract infections due to glycosuria providing a nutrient-rich environment for bacteria

Sexually transmitted infection (STI) testing

Urethritis exclusion

Tests for pathogens like Chlamydia and Gonorrhoea if urethral symptoms are present without typical cystitis symptoms

Clinical Pearls and Pitfalls

Repeat testing

Persistent symptoms

If symptoms persist after treatment, repeat urinalysis and culture to identify resistant organisms or alternative diagnoses

Follow-up cultures

Particularly important in recurrent cases to guide long-term management

Management

First-line Therapy

Antibiotic Therapy

Nitrofurantoin:
- 50-100 mg, 6 hourly for 5-7 days
Trimethoprim-sulfamethoxazole:
- 160/800 mg (1 double-strength tablet) twice daily for 3-5 days
- Minimum dosage for long-term treatment of >14 days: 80mg/400mg, twice daily
Fosfomycin:
- 3 grams single dose
The choice of antibiotic may be guided by local resistance patterns and patient allergy history

Symptomatic Relief

Phenazopyridine:
- 200 mg three times daily for 2 days to alleviate dysuria. (Not to be used for more than 2 days due to potential toxicity)

Hydration

Encourage increased fluid intake to help flush out the urinary tract

Second-line Therapy

Alternative Antibiotics

Fluoroquinolones (e.g., ciprofloxacin):
- For mild to moderate acute and uncomplicated infections: 250 mg twice daily for 3-5 days (reserved due to resistance concerns)
Beta-lactams (e.g., amoxicillin-clavulanic acid):
- 250/125 mg three times daily for 5-7 days; or
- 500/125 mg three times daily for 5-7 days; or
- 875/125 mg two times daily for 5 days
- Strength choice is dependent on the severity of the infection

Treatment for Complicated Cases

Longer duration of antibiotics:
- May be required for patients with underlying conditions such as diabetes, structural abnormalities, or immunosuppression
Intravenous antibiotics:
- Consider if oral therapy is not feasible or if the patient presents with severe symptoms or complications

Non-pharmacological Therapy

Behavioural modifications

Encourage urination before and after sexual activity to reduce the risk of infection
Advise wiping front to back to prevent bacterial spread from the anal area to the urethra
Recommend avoiding irritants such as caffeine, alcohol, and spicy foods that can aggravate bladder symptoms

Cranberry products

May help prevent recurrent infections, though the evidence is mixed. Ensure patients choose low-sugar options if using

Referral

Indications for referral to a nephrologist

Recurrent infections:
- Frequent UTIs (>2 in 6 months or >3 in a year) despite appropriate therapy
Complicated UTI:
- Presence of structural abnormalities, suspected urolithiasis, or underlying chronic disease
Atypical presentations:
- Symptoms that do not improve with standard treatment or suggest alternative diagnoses
Suspected interstitial cystitis or bladder pain syndrome:
- Chronic bladder pain without infection

Monitoring

Follow-up testing

Repeat urine culture if symptoms persist or recur within a few weeks of treatment
Monitor renal function in patients on long-term or recurrent antibiotic therapy

Patient education

Emphasise the importance of completing the full course of antibiotics even if symptoms resolve early
Educate patients about signs of complications (e.g., fever, flank pain) that warrant immediate medical attention

Follow-up

Routine follow-ups

Schedule follow-up visits to assess symptom resolution and adherence to preventive measures
Use symptom diaries to help identify patterns or triggers for recurrent infections

Long-term management

For patients with recurrent cystitis, consider prophylactic antibiotics (e.g., low-dose nitrofurantoin) or post-coital antibiotics
Encourage lifestyle modifications, such as maintaining proper hydration and regular urination habits

Medications

Drug Name

Nitrofurantoin
Trimethoprim-sulfamethoxazole
Fluoroquinolones (e.g., ciprofloxacin)
Beta-lactams (e.g., amoxicillin-clavulanic acid)

Posology (Dosage)

Drug	Dosage & Frequency	Clinical Notes
Nitrofurantoin	50-100 mg, 6 hourly for 5-7 days.	Adjust dosage based on symptom severity and patient response.
Trimethoprim-sulfamethoxazole	160/800 mg (1 double-strength tablet) twice daily for 3-5 days. Minimum dosage for long-term treatment of >14 days: 80mg/400mg, twice daily.
Ciprofloxacin	250 mg twice daily for 3-5 days.	This dose is for mild to moderate acute and uncomplicated infections. Adjust dosage based on symptom severity and patient response.
Amoxicillin-clavulanic acid	250/125 mg three times daily for 5-7 days; or 500/125 mg three times daily for 5-7 days; or 875/125 mg two times daily for 5 days.	Strength choice is dependent on the severity of the infection. Adjust dosage based on symptom severity and patient response.

Side Effects

Nitrofurantoin

Nausea
Vomiting
Acute and chronic pulmonary fibrosis
Liver enzyme elevation
Jaundice
Peripheral neuropathy
Tingling
Numbness

Trimethoprim-sulfamethoxazole

Nausea
Vomiting
Anorexia
Skin rash
Stevens-Johnson syndrome
Aplastic anaemia
Agranulocytosis
Thrombocytopenia
Hyperkalaemia (particularly in patients with renal impairment)

Ciprofloxacin

Nausea
Diarrhoea
Abdominal pain
Headache
Dizziness
Insomnia
Seizures
Tendonitis
Tendon rupture (increased risk in elderly and corticosteroid use)
QT prolongation
Risk of arrhythmias

Amoxicillin-clavulanic acid

Diarrhoea
Nausea
Vomiting
Pseudomembranous colitis
Hepatitis
Cholestatic jaundice
Hypersensitivity reactions
Rash
Anaphylaxis
Anaemia
Leukopenia
Thrombocytopenia

Interactions

Nitrofurantoin

Antacids containing magnesium trisilicate:
- Can reduce absorption
Fluoroquinolones:
- Antagonistic effect when used together
Probenecid and sulfinpyrazone:
- Can decrease renal excretion, increasing the risk of toxicity

Trimethoprim-sulfamethoxazole

Warfarin:
- Increases anticoagulant effect
- Risk of bleeding
Methotrexate:
- Increased risk of bone marrow suppression
Phenytoin:
- Increased serum levels and toxicity

Ciprofloxacin

Antacids, iron, and calcium supplements:
- Can significantly reduce absorption
Theophylline:
- Increased serum levels and risk of toxicity
Warfarin:
- Increased anticoagulant effect
- Risk of bleeding

Amoxicillin-clavulanic acid

Methotrexate:
- Increased risk of toxicity due to decreased renal clearance
Allopurinol:
- Increased risk of rash
Oral contraceptives:
- Reduced efficacy due to alteration of gut flora

Complications

Acute Complications

Pyelonephritis

Acute bacterial infection of the kidneys
Symptoms include high fever, flank pain, nausea, and vomiting
Requires hospitalisation and intravenous antibiotics

Urosepsis

Severe, life-threatening infection spreads from the urinary tract to the bloodstream
Symptoms include fever, chills, confusion, hypotension, and multi-organ dysfunction
Requires emergency medical intervention, including intravenous antibiotics and supportive care

Severe pain

Intense suprapubic pain that may necessitate emergency care
Pain management may include intravenous analgesics and observation

Haematuria

Significant blood in urine, which may indicate severe infection or other complications
Requires further investigation to rule out other conditions such as bladder cancer or kidney stones

Chronic Complications

Recurrent urinary tract infections (r-UTI)

Frequent episodes of cystitis, often requiring repeated courses of antibiotics
This may lead to increased antibiotic resistance and complications in future treatments

Chronic pain

Persistent lower abdominal or pelvic pain even after the resolution of acute infection
May significantly impact daily activities and quality of life

Bladder dysfunction

Chronic inflammation can lead to changes in bladder function, such as increased frequency and urgency
May result in interstitial cystitis or bladder pain syndrome

Renal scarring

Recurrent or severe infections can cause damage to the kidneys, leading to scarring
Can impair kidney function over time and increase the risk of chronic kidney disease

Impact on quality of life

Ongoing discomfort and frequent infections can lead to significant impairment in daily activities
Increased healthcare utilisation and economic burden due to medical expenses and loss of productivity

Psychological effects

Chronic stress, anxiety, and depression are associated with recurrent infections and persistent symptoms
May require integrated care addressing both physical and mental health aspects

Increased Antibiotic Resistance

Frequent use of antibiotics can lead to the development of resistant bacterial strains
Complicates future treatment options and may require more potent or combination antibiotic therapies

Preventive Measures

Prophylactic antibiotics

Consideration for patients with recurrent UTIs to prevent further episodes
Low-dose antibiotics or post-coital antibiotics may be prescribed

Patient education

Emphasise the importance of hydration, proper hygiene practices, and avoiding known triggers
Educate patients on recognising early symptoms and seeking timely medical intervention

Patient Education

Lifestyle Modifications

Hydration

Drink plenty of fluids, especially water, to help flush bacteria from the urinary tract
Avoid excessive consumption of caffeine and alcohol, which can irritate the bladder

Proper hygiene

Urinate before and after sexual activity to reduce the risk of infection
Wipe from front to back after using the toilet to prevent the spread of bacteria from the anal area to the urethra
Avoid the use of irritating feminine products such as douches, powders, and sprays

Dietary considerations

Maintain a balanced diet to support overall health
Cranberry products may help prevent recurrent infections but choose low-sugar options

Clothing

Wear loose-fitting, cotton underwear and avoid tight clothing to reduce moisture and promote a healthy urinary tract environment

Preventive Measures

Frequent urination

Do not hold urine for long periods; empty your bladder regularly
Respond promptly to the urge to urinate to avoid bacterial growth in the bladder

Avoiding triggers

Identify and avoid potential triggers that may irritate the bladder, such as spicy foods and artificial sweeteners

Support Resources

Patient support groups

Join local or online support groups for individuals with recurrent urinary tract infections to share experiences and coping strategies
Support groups provide emotional support and practical advice

Educational materials

Provide reliable information on the causes, symptoms, and management of acute cystitis
Educational brochures, websites, and apps can offer guidance and support

Dietary counselling

Consult with a registered dietitian to create a personalised diet plan that supports urinary tract health
Regular follow-ups with dietary counselling can assist in making necessary dietary adjustments

Medication Adherence

Importance of completing antibiotics

Educate patients on the importance of completing the full course of prescribed antibiotics even if symptoms improve early
Discuss potential side effects and how to manage them
Encourage keeping a medication diary to track dosages and effects

Symptom Tracking

Symptom diary

Encourage patients to keep a diary of symptoms to identify patterns and triggers
Symptom tracking can help in adjusting treatment plans and dietary choices

Communication with Healthcare Providers

Regular check-ins

Advise patients to maintain open communication with their healthcare team
Regular check-ins can help monitor symptom progression and the effectiveness of treatments
Patients should report any new or worsening symptoms promptly

Holistic Approaches

Complementary therapies

Explore complementary therapies such as acupuncture or herbal supplements, ensuring they are discussed with healthcare providers to avoid interactions
Emphasise the importance of a balanced approach that includes conventional medical treatments and lifestyle modifications

Long-Term Management

Ongoing care

Educate patients that recurrent UTIs may require ongoing management
Set realistic expectations about symptom control and the potential need for long-term lifestyle adjustments
Encourage patients to take an active role in their care and decision-making process

References and Guidelines

Key References

Sorensen M, Walsh TJ, Haider MA. Genitourinary Tract Infections. In: Papadakis MA, McPhee SJ, Rabow MW, editors. Current Medical Diagnosis & Treatment 2024. New York: McGraw-Hill; 2024

Clinical Guidelines

NICE Guidelines on Urinary tract infection (lower): antimicrobial prescribing (NG109):
- National Institute for Health and Care Excellence (NICE) guidelines provide evidence-based recommendations on the diagnosis and management of UTIs in adults. These guidelines emphasise the importance of accurate diagnosis, appropriate antibiotic use, and patient education to prevent recurrent infections
IDSA Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults:
- The Infectious Diseases Society of America (IDSA) offers guidelines focused on the management of asymptomatic bacteriuria, distinguishing it from symptomatic infections like acute cystitis to prevent unnecessary antibiotic use
EAU Guidelines on Urological Infections:
- European Association of Urology (EAU) provides comprehensive guidelines on the management of urological infections, including acute cystitis. These guidelines cover diagnostic criteria, treatment options, and preventive strategies tailored to different patient populations
SAASP Guidelines for Antibiotic Prescribing in South Africa:
- The South African Antibiotic Stewardship Programme (SAASP) guidelines focus on the rational use of antibiotics in South Africa, aiming to reduce antibiotic resistance. These guidelines include specific recommendations for the treatment of acute cystitis and other UTIs
WHO Guidelines on UTI Management:
- The World Health Organisation (WHO) provides global recommendations for the diagnosis and treatment of UTIs, focusing on the use of appropriate antibiotics and the importance of monitoring resistance patterns

Notes for HCPs

Clinical Pearls and Pitfalls

Ensure patient compliance with treatment

Educate patients on the importance of completing the full course of antibiotics even if symptoms improve early
Provide clear instructions on taking medications, including the timing of doses and potential side effects

Monitor for drug interactions

Regularly review patients' medication lists to identify potential interactions with antibiotics used for acute cystitis
Be cautious with the use of nitrofurantoin in patients with renal impairment and avoid concomitant use with certain antacids

Recognise and manage recurrent infections

Screen for underlying conditions that may predispose patients to recurrent UTIs, such as diabetes or anatomical abnormalities
Consider prophylactic antibiotics or post-coital antibiotics for patients with frequent recurrences

Evaluate and address lifestyle factors

Encourage patients to maintain adequate hydration and regular urination habits
Advise on proper hygiene practices, such as wiping from front to back and urinating before and after sexual activity

Be vigilant for complications

Promptly investigate symptoms such as high fever, flank pain, and haematuria that may indicate complications like pyelonephritis or urosepsis
Refer to a specialist if there are signs of complicated UTI or if initial treatment fails

Customise treatment plans

Tailor antibiotic choice is based on local resistance patterns and individual patient factors, such as allergies and renal function
Adjust treatment duration for complicated cases or underlying conditions

Educate patients about prevention

Discuss preventive measures, including lifestyle modifications and possible use of cranberry products or D-mannose
Provide information on recognising early symptoms of UTI and seeking timely medical intervention

Consider the use of non-pharmacological interventions

Suggest behavioural modifications and lifestyle changes to reduce the risk of future infections
Educate on the potential benefits of probiotics in maintaining a healthy urinary tract environment, though the evidence is mixed

Screen for and manage psychological comorbidities

Recognise that recurrent infections can lead to anxiety and decreased quality of life
Consider referrals to mental health professionals if psychological distress is significant

Set realistic expectations

Educate patients that while treatment is effective, some individuals may experience recurrent infections
Emphasise the importance of ongoing preventive measures and regular follow-ups for long-term management

Clinical Highlights

Recognise and diagnose acute cystitis based on symptoms and urinalysis results
Start appropriate antibiotic therapy promptly to prevent complications and ensure rapid symptom relief
Use nitrofurantoin, trimethoprim-sulfamethoxazole, or fosfomycin as first-line treatments
Adjust antibiotic choice based on local resistance patterns and individual patient factors
Encourage increased fluid intake to help flush bacteria from the urinary tract
Use phenazopyridine for short-term relief of dysuria, but limit use to 2 days due to potential toxicity
Be aware of interactions between antibiotics and other medications, such as antacids with nitrofurantoin or warfarin with trimethoprim-sulfamethoxazole
Educate patients on lifestyle modifications to prevent recurrent infections, such as proper hygiene practices and urinating before and after sexual activity
Consider prophylactic antibiotics for patients with frequent recurrences
Be vigilant for signs of complications like pyelonephritis or urosepsis, which require immediate medical intervention
Monitor patients for chronic complications such as recurrent UTIs and bladder dysfunction
Provide comprehensive education on the importance of completing the full course of antibiotics
Discuss preventive strategies and lifestyle modifications to reduce the risk of future infections
Schedule follow-up visits to assess symptom resolution and adherence to preventive measures
Use symptom diaries to help patients identify patterns and triggers
Refer patients to a specialist if they have recurrent infections, complicated UTIs, or atypical symptoms
Consider referral for further evaluation if initial treatments fail or if there are underlying conditions
Encourage a balanced approach that includes medical treatment, lifestyle modifications, and complementary therapies when appropriate
Address psychological aspects, as recurrent infections can impact mental health

Field	Triage	Clinical Setting	Condition Type
Urology	Non-Emergency	Outpatient	Acute

Overview

Condition

Epidemiology

Risk Factors

Definition and Pathophysiology

Definition

Pathophysiology

Clinical Presentation

Symptoms

Signs

Diagnostic Criteria

Additional Diagnostic Considerations

Functional Impact

Differential Diagnosis

Conditions to Consider

Key Differentiators

Diagnostic Tests

Initial Tests

Advanced Tests

Imaging Studies

Additional Diagnostic Considerations

Clinical Pearls and Pitfalls

Management

First-line Therapy

Second-line Therapy

Non-pharmacological Therapy

Referral

Monitoring

Follow-up

Medications

Drug Name

Posology (Dosage)

Side Effects

Complications

Acute Complications

Chronic Complications

Preventive Measures

Patient Education

Lifestyle Modifications

Preventive Measures

Support Resources

Medication Adherence

Symptom Tracking

Communication with Healthcare Providers

Holistic Approaches

Long-Term Management

References and Guidelines

Key References

Clinical Guidelines

Notes for HCPs

Clinical Pearls and Pitfalls

Clinical Highlights

Recommended reads

Drugs mentioned

ICD-10 codes